HPV, cervical dysplasia and cervical cancer
Cervical dysplasia is an abnormal change in the cells of the cervix in the uterus. Early changes, called low-grade lesions by doctors, may persist and develop into high-grade lesions that can lead to cervical cancer. Mildly abnormal cervical cells will usually clear up on their own. Both cervical dysplasia and cervical cancer can be best treated effectively when they are caught early. A sexually transmitted virus called HPV (human papillomavirus) causes most cervical dysplasia and all cervical cancers. Cervical dysplasia is common in HIV-positive people who have a cervix. However, among HIV-positive people living in high-income countries who get regular gynecological monitoring and care, cervical cancer is not common.
The words we use here – CATIE is committed to using language that is relevant to everyone. People use different terms to describe their genitals. This text uses medical terms, such as vagina and penis, to describe genitals. Cisgenderi people can often identify with these terms. Some transgenderii people may use other terms, such as front hole and strapless. CATIE acknowledges and respects that people use words that they are most comfortable with.
Dysplasia and cancer of the cervix
The cervix is the opening of the uterus (womb) that leads into the vagina. The cervix can be felt with the tip of a finger inside the vagina.
In cervical dysplasia, abnormal cells develop on the surface of the cervix. These abnormal cells are called lesions. Cervical dysplasia lesions can regress (which means they shrink and may even disappear), persist (the lesions remain present but don’t change), or progress to become a high-grade lesion or cervical cancer.
Cervical cancer is an abnormal growth of the cells of the cervix. Over a number of years, abnormal lesions on the cervix can slowly turn into cancer.1–3
What causes cervical dysplasia and cancer?
Cervical dysplasia and cancer have been linked to a very common virus called human papillomavirus (HPV). There are over 100 strains of HPV, about 40 of which can be transmitted sexually. Some strains cause warts, including genital warts (abnormal growths on the skin), some lead to cancer of the genitals or anus, the intestines or the lungs, throat and mouth. Some have no known effect.
The immune system helps protect against the development of cervical dysplasia and cancer. People whose immune systems are weakened by transplant drugs or illnesses such as HIV are at greater risk for HPV infection, cervical dysplasia, and cervical cancer. Women and transgender men who have HIV are at higher risk, and this risk seems to increase as the CD4 counts drop.
Although HPV is necessary for cervical cancer, other factors contribute to the development of cervical dysplasia and cancer. Cigarette smoking has been linked to this condition. Cancer-causing chemicals in cigarette smoke concentrate in cervical fluids and these can affect the health of cervical cells, increasing the risk that these cells become abnormal. Having had a prior sexually transmitted infection (STI), having been pregnant many times, or eating a poor diet can also increase the risk of cervical dysplasia and cancer. Because HPV is sexually transmitted, having multiple sexual partners will increase a person's risk of being exposed to this virus. However, even people with few partners are still at risk of being infected by HPV.3–6
Usually, there are no symptoms of cervical dysplasia. Genital warts are a sign that someone has been exposed to certain types of HPV, which are different from the types that are most likely to lead to cervical dysplasia and cancer. It is important to note that people can have HPV and not have genital warts or any other symptoms.
Similarly, there are often no physical symptoms of cervical cancer, especially in the early stages. In advanced stages of cervical cancer, there may be pain in the abdomen or lower back, pain or bleeding while having vaginal intercourse, unusual vaginal discharge, or bleeding between menstrual periods.2,3
Diagnosis—Pap smears and colposcopy
Regular pelvic examinations including Pap tests and HPV testing can help diagnose or monitor HPV, cervical dysplasia or cancer. To do a Pap test, the doctor inserts a tiny brush and a small wooden spatula into the vagina and rubs them over the cervix to loosen and collect cells. The cells are smeared on a glass slide that is sent to the lab for study. The Pap test helps identify abnormal cells. For people with HIV, Pap tests are usually done twice during the first year after HIV diagnosis, followed by once a year if the first two tests showed normal results. However, many physicians with HIV-positive people in their care recommend doing a Pap test every six months.
Although Pap tests are useful, they can produce "false-negative" results. In other words, the lab may report a test result as "normal" when there actually are changes in the cells of the cervix. This is the reason why HPV testing is being used more and more in addition to Pap tests. For HPV testing, doctors can collect a small amount of fluid from the cervix and have it tested for the presence of HPV.
Many doctors recommend that people with a cervix who have been newly diagnosed with HIV have a colposcopy. A colposcope is a microscope that looks into the vagina, which has been opened by a speculum, and allows the doctor to visually examine the cervix. The cervix is lightly washed with a weak vinegar solution before the colposcope is put in place. The vinegar solution makes abnormal cells stand out more clearly against the surrounding tissue.
When a colposcopy is performed, a biopsy (removal of a tiny piece of tissue from the cervix) and sometimes an endocervical curettage (the scraping of tissue from the cervix) will be done by the doctor. This procedure can be somewhat painful or cause cramps. The biopsy sample allows lab technicians to study the tissue and confirm the status of cervical tissue.
Pap tests are done by family physicians and gynecologists as part of regular medical care. However, colposcopies and biopsies are done mostly, but not exclusively, by gynecologists.
An HIV-positive person with signs of abnormalities on the cervix, vagina, or vulva should also have an anoscopy, or visual inspection of the anus and anal canal using a microscope similar to a colposcope. This is because the cell changes caused by HPV can also occur in the anus and lead to anal dysplasia.1,7
The results of tests for cervical dysplasia can be described by a variety of medical terms.
Pap test results
Here are some of the most common test results:
- Normal: There is no evidence of abnormal changes in the cells sampled.
- ASCUS (Atypical Squamous Cells of Undetermined Significance): The cells are abnormal, but no definite diagnosis can be made. This test result can be caused by a yeast infection, using oral contraceptives, or problems with taking the sample. Usually doctors repeat the Pap test in a few weeks or test for the presence of high risk types of HPV.
- LSIL (Low-grade Squamous Intra-epithelial Lesion): This result means an acute infection. If it persists for at least two to three visits, it can be assumed that it could lead to cancer.
- HSIL (High-grade Squamous Intra-epithelial Lesion): This result means more advanced lesions.
- AGC (Atypical Glandular Cells): These abnormal cells are the precursors of about 20% of cervical cancers. These cells are very difficult to detect.
- Normal: There is no evidence of abnormal changes in the sampled cells.
- CIN-1 (Cervical Intra-epithelial Neoplasia, grade 1): This result means mild or low-grade dysplasia. If it persists for at least two to three visits, it can be assumed that it could lead to cancer. For this reason, CIN-1 is usually treated.
- CIN- 2 or CIN-3: This result means severe or high-grade dysplasia. All or almost all of the cells in the sample may be pre-cancerous and indicates the need for treatment in most cases.
- CIS: CIS stands for carcinoma in situ and means a small area of cancer has been found. Further tests will be done to find out if the cancer is confined to a small area or if it has spread (called invasive carcinoma).
If someone is diagnosed with HPV, partner notification is not required as a public health measure, unlike with a chlamydia, gonorrhea, syphilis or HIV diagnosis.3,6,8,9
Treatment for cervical dysplasia and cancer varies from one person to another, depending on the location and size of the lesion or cancer, and whether the lesion is low grade or high grade or whether the cancer has spread to other parts of the body. Whether or not the person wishes to become pregnant also affects treatment decisions. People with cervical cancer may be referred to a gynecologist-oncologist or an oncologist—a doctor who specializes in the treatment of cancer.
There are several ways that cervical dysplasia may be treated:
- Cryotherapy destroys the lesion by freezing. This procedure can be done in the doctor’s office. There can be some discomfort or pain. After the treatment, spotting and watery discharge are common.
- Laser treatment destroys the lesion with an intense beam of light. This procedure is often done in a day-surgery clinic. It can be uncomfortable and can cause spotting and discharge afterward.
- LEEP stands for loop electrosurgical excision procedure. The lesion is surgically removed by an electrical current that passes through a very fine wire loop and cauterizes the cervix at the same time so that it does not bleed afterward.
- Cone biopsy removes a cone-shaped piece of tissue from the opening of the cervix and can remove a lesion or very small cancer. It is usually done in a hospital with a laser or a scalpel and patients are given an anesthetic. Some bleeding and pain or discomfort is common after this treatment.
There are several treatment options if cancer is confirmed:
- Surgery may be used to remove cancerous tissue. If the cancer has spread, surgery to remove the cervix and uterus, called a hysterectomy, may be necessary. Sometimes the fallopian tubes, ovaries and lymph nodes from the pelvis are removed at the same time.
- Radiation therapy is often prescribed for cervical cancer that has spread beyond the cervix. In radiation therapy, high-energy rays are used to kill cancer cells.
- Chemotherapy may be used by itself or in addition to radiation therapy if the cancer has spread. Anticancer drugs are used in the blood to kill cancer cells.3,7,9
Although cervical dysplasia and cancer can be treated successfully, HIV-positive individuals are at high risk for having this cancer reappear. It is important to follow up treatment with regular Pap tests and a colposcopy every three to six months.10
Cervical dysplasia, HIV and ART
Because HIV and HPV are sexually transmitted, HIV-positive people are often co-infected with both of these viruses. HIV weakens the immune system and in HIV-positive individuals, cervical dysplasia is common.
Taking ART (HIV antiretroviral therapy) can reduce the production of HIV, improve CD4 cell counts, and greatly lower the risk of developing many AIDS-related illnesses. ART cannot prevent cervical cancer. However, with regular gynecological exams and Pap tests, studies have found that cervical cancer is not common in these individuals in high-income countries.11
Practising safer sex by using condoms or having non-penetrative sex can help reduce the risk of becoming infected with HPV. However, condoms do not completely eliminate the risk of HPV transmission because the virus may be present on skin not covered by the condom. Condoms also reduce the risk of other STIs that contribute to the development of dysplasia and cancer. Stopping cigarette smoking can help reduce the risk of cervical dysplasia and cancer.
Three vaccines against HPV genotypes are available in Canada. Gardasil is approved for use in “females and males aged 9 to 26.” It protects against HPV types 16 and 18, which cause approximately 70% of cervical cancers, as well as HPV types 6 and 11, which do not cause cancer but cause approximately 90% of warts on or around the genitals and anus. Gardasil 9 protects against HPV types 6, 11, 16 and 18 as well as types 31, 33, 45, 52 and 58 which can also cause cancer. Cervarix is only approved for use in “females aged 10 to 25.” It protects against HPV types 16 and 18 only.
In clinical trials with cisgenderi girls and young women, the vaccines have provided a very high level – over 90% – of protection against complications, such as cervical and anal dysplasias and genital warts, related to the HPV genotypes targeted. Indicators of protective effects have lasted for at least 10 years after vaccination in some trials. For either vaccine to work, three doses given over six months are necessary.
The vaccines do not provide protection against HPV that people are already infected with, but provide excellent protection against HPV the person has not been exposed to. Also the vaccines have not been shown to be effective for the treatment of established HPV infection and are not approved in Canada for this use. Gardasil and Cervarix should be avoided in people who are pregnant. Gardasil can be given to people who are breastfeeding, while Cervarix should only be used during breastfeeding when the possible advantages outweigh the possible risks.
It is important to remember that even if someone has received one of the vaccines, they are only protected against the cancer-causing HPV types covered by the vaccine they have received. Regular medical check-ups with pelvic examinations and cervical cancer screening with Pap tests for women and transmen in their 20s and viral testing starting in their 30s are still needed to help all people, regardless of their HIV status, reduce their risk of cervical cancer and watch for signs of cervical dysplasia and cancer.1,3,5,12–15
The bottom line
Cervical dysplasia is not cancer but must be treated to prevent the possibility of it developing into cancer. Cervical cancer is a serious condition, especially for HIV-positive people. The earlier it is found, the better the chances are for successful treatment.
The risk of acquiring HPV, developing cervical dysplasia and cervical cancer may be reduced by:
- getting one of the HPV vaccines
- practising safer sex to reduce the risk of HPV infection
- quitting cigarette smoking
- getting regular Pap tests and, if appropriate, colposcopies and anoscopies
- if HIV positive, taking an effective ART combination3,7,10,15
i Cisgender – someone whose gender identity aligns with the sex they were assigned at birth
ii Transgender – an umbrella term that describes people with diverse gender identities and gender expressions that do not conform to stereotypical ideas about what it means to be a girl/woman or boy/man in society .
(Definitions taken from Creating Authentic Spaces: A gender identity and gender expression toolkit to support the implementation of institutional and social change, published by The 519, Toronto, Ontario.)
- Centers for Disease Control and Prevention. Human Papilloma Virus (HPV). Available at: http://www.cdc.gov/std/hpv/pap/default.htm#glosscolp [Accessed July 7th, 2015]
- Ontario’s Ministry of Health and Long-Term Care. Ontario’s Vaccination program. Available at: http://www.health.gov.on.ca/en/ms/hpv/about_hpv.aspx [Accessed July 7th 2015]
- World Health Organization. Human Papillomavirus (HPV) and cervical cancer. Available at: http://www.who.int/mediacentre/factsheets/fs380/en/ [Accessed July 7th 2015]
- Alam S, Conway MJ, Chen HS, et al. The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis. Journal of Virology. 2008 Jan;82(2):1053–1058.
- Chan JK, Berek JS. Impact of the human papilloma vaccine on cervical cancer. Journal of Clinical Oncology. 2007;25(20):2975–2982.
- Massad LS, Seaberg EC, Wright RL, et al. Squamous cervical lesions in women with human immunodeficiency virus. Obstetrics and Gynecology. 2008 Jun;111(6):1388–1393.
- John Hopkins Medicine. Cervical Biopsy. Available at: http://www.hopkinsmedicine.org/healthlibrary/test_procedures/gynecology/cervical_biopsy_92,P07767/ [Accessed July 7th 2015]
- Maiman M, Watts DH, Andersen JL, et al. Vaginal 5-fluorouracil for high-grade cervical dysplasia in human immunodeficiency virus infection: a randomized trial. Obstetrics and Gynecology. 1999;94:954–961.
- National Cancer Institute. Pap and HPV Testing. Available at: http://www.cancer.gov/types/cervical/pap-hpv-testing-fact-sheet. [Accessed July 7th 2015]
- Strickler HD, Burk RD, Fazzari M, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. Journal of the National Cancer Institute. 2005 Apr 20;97(8):577–586.
- Massad LS, Seaberg EC, Watts DH, et al. Low incidence of invasive cervical cancer among HIV-infected US women in a prevention program. AIDS. 2004 Jan 2;18(1):109–113.
- Public Health Agency of Canada. Human Papillomavirus (HPV) Prevention and HPV Vaccines: Questions and Answers. Available at: http://www.phac-aspc.gc.ca/std-mts/hpv-vph/hpv-vph-vaccine-eng.php#a2 [Accessed July 7th 2015]
- Barr E and Tamms G. Quadrivalent human papillomavirus vaccine. Clinical Infectious Diseases 2007 Sep 1;45(5):609–607.
- GlaxoSmithKline Canada. Cervarix (Human Papillomavirus vaccine Types 16 and 18 (Recombinant, AS04 adjuvanted)). Product Monograph. May 2, 2013.
- Heard I, Schmitz V, Costagliola D, et al. Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS. 1998; 12:1459-1464.
This fact sheet was developed in partnership with the Sex Information and Education Council of Canada (SIECCAN).
Author(s): Maclean D, Ollner A, Hosein SR